Horizon Pharma reported $646.39M in Trade Debtors for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Trade Debtors Change
ALKERMES ALKS:US USD 267.28M 4.95M
Amgen AMGN:US USD 5.56B 237M
AstraZeneca AZN:LN USD 10.06B 449M
Cara Therapeutics CARA:US USD 10.77M 1.6M
Coherus Biosciences CHRS:US USD 91.19M 24.52M
Endo International Ordinary Shares ENDP:US USD 425.95M 75.15M
Horizon Pharma HZNP:US USD 646.39M 26.92M
JAZZ PHA JAZZ:US USD 601.18M 7.14M
Novartis NOVN:VX USD 8.68B 230M
Pacira Pharmaceuticals PCRX:US USD 93.47M 2.37M
Perrigo Ordinary Shares PRGO:US USD 739.5M 37.6M
Prestige Brands PBH:US USD 157.08M 11.09M
Revance Therapeutics RVNC:US USD 11.73M 6.14M
Supernus Pharmaceuticals SUPN:US USD 164.09M 6.02M
Takeda 4502:JP JPY 779.87B 20.66B
Teva Pharmaceutical Industries TEVA:US USD 3.73B 741M
Valeant Pharmaceuticals VRX:CN USD 1.74B 94M
Xeris Pharmaceuticals Inc XERS:US USD 27.52M 1.76M
Zoetis ZTS:US USD 1.19B 102M